These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 26927060)
1. Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome. Rigante D; Andreozzi L; Fastiggi M; Bracci B; Natale MF; Esposito S Int J Mol Sci; 2016 Feb; 17(3):278. PubMed ID: 26927060 [TBL] [Abstract][Full Text] [Related]
2. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease. Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598 [TBL] [Abstract][Full Text] [Related]
3. Predicting IVIG resistance in UK Kawasaki disease. Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405 [TBL] [Abstract][Full Text] [Related]
4. The factors affecting the disease course in Kawasaki disease. Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M; Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183 [TBL] [Abstract][Full Text] [Related]
6. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities. Loomba RS; Raskin A; Gudausky TM; Kirkpatrick E Am J Ther; 2016; 23(6):e1293-e1299. PubMed ID: 25611359 [TBL] [Abstract][Full Text] [Related]
7. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort. Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051 [TBL] [Abstract][Full Text] [Related]
8. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rigante D; Valentini P; Rizzo D; Leo A; De Rosa G; Onesimo R; De Nisco A; Angelone DF; Compagnone A; Delogu AB Rheumatol Int; 2010 Apr; 30(6):841-6. PubMed ID: 20049445 [TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease: a comprehensive review of treatment options. Patel RM; Shulman ST J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265 [TBL] [Abstract][Full Text] [Related]
10. Kawasaki disease in Sicily: clinical description and markers of disease severity. Maggio MC; Corsello G; Prinzi E; Cimaz R Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720 [TBL] [Abstract][Full Text] [Related]
11. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population? Edraki MR; Mohammadi H; Mehdizadegan N; Ghorashi M; Amoozgar H; Borzouee M; Ajami G; Keshavarz K; Dehghani E; Bahrami R Arch Iran Med; 2020 Jan; 23(1):31-36. PubMed ID: 31910632 [TBL] [Abstract][Full Text] [Related]
12. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease. Wei M; Huang M; Chen S; Huang G; Huang M; Qiu D; Guo Z; Jiang J; Zhou X; Yu Q; Guo Y; Fu L; Gao W; Li F Pediatr Cardiol; 2015 Aug; 36(6):1166-72. PubMed ID: 25812827 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Ruan Y; Ye B; Zhao X Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan. Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Chen S; Dong Y; Yin Y; Krucoff MW Heart; 2013 Jan; 99(2):76-82. PubMed ID: 22869678 [TBL] [Abstract][Full Text] [Related]
17. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome. Saulsbury FT Clin Pediatr (Phila); 2002 Oct; 41(8):597-601. PubMed ID: 12403377 [TBL] [Abstract][Full Text] [Related]
18. The Harada score in the US population of children with Kawasaki disease. Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993 [TBL] [Abstract][Full Text] [Related]
19. Novel Score to Predict Immunoglobulin Resistance in Kawasaki Disease. Natarajan RK; Bhoopalan SV; Cross C; Shah R; Rothman A Pediatr Cardiol; 2023 Oct; 44(7):1546-1551. PubMed ID: 37173579 [TBL] [Abstract][Full Text] [Related]
20. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population. Sánchez-Manubens J; Antón J; Bou R; Iglesias E; Calzada-Hernandez J; Borlan S; Gimenez-Roca C; Rivera J; Rheumatol Int; 2016 Jul; 36(7):905-10. PubMed ID: 27215220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]